May 22, 2013 6:41 AM ET

Pharmaceuticals

Company Overview of Psyadon Pharmaceuticals, Inc.

Company Overview

Psyadon Pharmaceuticals, Inc. engages in the discovery and development of drugs for the treatment of diseases afflicting the central nervous system, primarily neurological and psychiatric diseases. Its Ecopipam product is an antagonist of the D1 dopamine receptor that blocks the actions of the neurotransmitter dopamine at the D1 receptor-family in the brain. Psyadon Pharmaceuticals, Inc. was formerly known as Ruxton Pharmaceuticals, Inc. and changed its name in November 2008. The company was founded in 2004 and is based in Germantown, Maryland.

20451 Seneca Meadows Parkway

Germantown, MD 20876

United States

Founded in 2004

Phone:

301-919-2020

Fax:

301-919-2020

www.psyadonrx.com

Key Executives for Psyadon Pharmaceuticals, Inc.

Chief Executive Officer and President
Compensation as of Fiscal Year 2012.

Psyadon Pharmaceuticals, Inc. Key Developments

Psyadon Pharmaceuticals, Inc. Presents at Mid-Atlantic Bio Conference, Sep-27-2012

Psyadon Pharmaceuticals, Inc. Presents at Mid-Atlantic Bio Conference, Sep-27-2012 . Venue: Bethesda North Marriott Hotel & Conference, Bethesda, Maryland, United States.

Psyadon Pharmaceuticals, Inc. Announces Positive Interim Analysis of Phase 2 Study of Ecopipam for the Treatment of Tourette Syndrome

Psyadon Pharmaceuticals, Inc. announced that its Phase 2 study of ecopipam in patients with Tourette Syndrome was stopped early when a planned interim analysis revealed a statistically significant reduction in the severity of the patients' tic symptoms. This decision was supported by both the independent Drug Safety and Monitoring Committee overseeing the study and by the external Research Committee established as part of Psyadon's partnership with the Tourette Syndrome Association.

Psyadon Pharmaceuticals, Inc. Presents at 10th Annual BIO Investor Forum, Oct-25-2011

Psyadon Pharmaceuticals, Inc. Presents at 10th Annual BIO Investor Forum, Oct-25-2011 . Venue: Palace Hotel, 2 New Montgomery Street, San Francisco, California, United States.

Similar Private Companies By Industry

Company Name Region
Protea Biosciences Group, Inc United States
CytoSolv Inc. United States
Synomics Pharmaceutical Services LLC United States
Alacritas Biopharma, Inc. United States
Cardinal Health 100, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
Rush University United States
Greater Houston Partnership United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Psyadon Pharmaceuticals, Inc., please visit www.psyadonrx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.